Contineum Therapeutics Stock (NASDAQ: CTNM) stock price, news, charts, stock research, profile.
You can purchase shares of Contineum Therapeutics (NASDAQ:CTNM) through any online brokerage.
Other companies in Contineum Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Bioage Labs (NASDAQ:BIOA), Terns Pharma (NASDAQ:TERN) and Neumora Therapeutics (NASDAQ:NMRA).
Contineum Therapeutics has a consensus price target of $29.25.
The stock price for Contineum Therapeutics (NASDAQ: CTNM) is $7.53 last updated February 25, 2025 at 4:00 PM EST.
There are no upcoming dividends for Contineum Therapeutics.
Contineum Therapeutics’s Q1 earnings are confirmed for Friday, May 16, 2025.
There is no upcoming split for Contineum Therapeutics.
Contineum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.